Horizon Therapeutics (NASDAQ:HZNP) reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Horizon Therapeutics missed estimated earnings by 25.89%, reporting an EPS of $0.83 versus an estimate of $1.12.
Revenue was down $53.19 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 0.08% drop in the share price the next day.
Here’s a look at Horizon Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 1.09 | 1.01 | 1.35 | 1.20 |
| EPS Actual | 1.21 | 1.25 | 1.07 | 1.34 |
| Revenue Estimate | 922.92M | 888.32M | 936.10M | 874.41M |
| Revenue Actual | 942.00M | 925.36M | 876.41M | 885.25M |
To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
